Skip to content

Effect of extraocular myofascial technique in treatment of strabismus

Evaluation of the efficacy of extraocular myofascial technique on non-accommodative Eso deviations

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20210130050183N1
Enrollment
12
Registered
2021-02-15
Start date
2021-02-19
Completion date
Unknown
Last updated
2021-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Non-accommodative Esotropia due to spasm of convergence. Condition 2: Non-accommodative Esophoria due to spasm of convergence. Convergent concomitant strabismus Heterophoria

Interventions

Intervention group: In the first week, we will have no treatment
then, the therapeutic intervention will be done. It includes the myofascial release technique for the medial rectus muscle and its related connective tissue for at least 300 seconds per eye twice in a

Sponsors

Iran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 35 Years

Inclusion criteria

Inclusion criteria: Less than +1.00 D cyclo-refraction Corrected visual acuity of 20/20 or better Esophoria or Esotropia at far or near after complete refractive correction Normal gradient AC/A ratio (2.86±2.40) (Mean ± SD) Comitancy in angle of deviation Recent onset of the deviation or its symptoms (less than one year ago)

Exclusion criteria

Exclusion criteria: Improper use of spectacle glasses (if the subject has a refractive error) Use of any drug affecting the central nervous system during study period Any underlying disease and drug usage History of the head or eye trauma History of strabismus surgery Suffering COVID-19 or any symptoms of the disease

Design outcomes

Primary

MeasureTime frame
Magnitude of the Eso deviation. Timepoint: At the initial visit - after one week without treatment - after one week of therapeutic intervention. Method of measurement: Cover-test and Prism bar.

Secondary

MeasureTime frame
Saccadic Movement Velocity. Timepoint: After one week without treatment - after one week of therapeutic intervention. Method of measurement: Dynamic Electrooculography.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAlireza Mohamadi

Iran University of Medical Sciences

alremone@gmail.com+98 21 2227 8565

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026